Real-life Scientific Study Demonstrates BENEO’s Ingredients Suit a Personalized Nutrition Approach
PARSIPPANY, NJ / ACCESSWIRE / March 8, 2022 / A recently published study conducted by Perfood GmbH, Germany, in collaboration...
Day: March 9, 2022
ClareMedica Health Partners Sets Course For Major Expansion
Revelstoke Capital Partners' Equity Investment to Provide Growth CatalystMIAMI LAKES, FL / ACCESSWIRE / March 8, 2022 / ClareMedica Health...
Cloud DX Signs Contract with US University Nursing School
Cloud DX supplies Virtual Care and Remote Patient Monitoring hardware and services to educate the next generation of nurses and...
Biotricity Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and moreREDWOOD CITY, CA / ACCESSWIRE...
Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
NEW YORK, NY / ACCESSWIRE / March 8, 2022 / Evonik Industries AG, a leading global supplier of specialty chemicals,...
IIOT-OXYS, Inc. Signs NDA with Canadian Indoor Air Quality IIoT Start-Up
CAMBRIDGE, MA / ACCESSWIRE / March 8, 2022 / IIOT-OXYS, Inc. (OTC PINK:ITOX) (the "Company") announces the execution of a...
Aytu BioPharma to Participate in the 34th Annual Roth Conference
ENGLEWOOD, CO / ACCESSWIRE / March 8, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Metastatic Head and Neck Cancer
ROCHESTER, N.Y., March 09, 2022 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach...
Portage Biotech Announces Presentation of PORT-5 (STI-001) Late-Breaking Data at AACR 2022 Annual Meeting
Preclinical data will be presented in a late-breaking abstract sessionWESTPORT, Conn., March 09, 2022 (GLOBE NEWSWIRE) -- Portage Biotech Inc....
Rockwell Medical Announces Upcoming Poster Presentation at the National Home Infusion Association’s 2022 Annual Conference
WIXOM, Mich., March 09, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical...
Omada Health Announces Integrated Behavioral Health Support Across Chronic Care Programs
The digital health company deepens its investment in behavioral health across core programsSAN FRANCISCO, March 09, 2022 (GLOBE NEWSWIRE) --...
Fortress Biotech to Participate in Three March 2022 Investor Conferences
MIAMI, March 09, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently...
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Year Ended December 31, 2021 Financial Results
Sales for 2021 of $68.6 million, Second Highest in Company History, Only Exceeded by Record Year Comparable Sales in 2020...
Ortho Clinical Diagnostics Wins Bronze Stevie® Award for Customer Service and Support
Ortho Care® Service and Support recognized for dedication to solving customer challenges with unique solutions that deliver exceptional patient careRARITAN,...
BBS Bioactive Bone Substitutes Plc has filed the CE-marking application of Artebone® bone void filler to the authorities
BBS-Bioactive Bone Substitutes Plc, Company Release, Inside Information, March 9, 2022 at 3:30 p.m. BBS Bioactive Bone Substitutes Plc has...
Dentsply Sirona Announces $150 Million Accelerated Share Repurchase Program
CHARLOTTE, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that it has...
eGenesis Announces Research Collaboration with the University of Miami to Evaluate Human Compatible Islet Cells in Diabetes Model
CAMBRIDGE, Mass., March 09, 2022 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing company developing human-compatible (HuCo™) organs and cells, today announced...
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th
LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST),...
Palisade Bio (Nasdaq: PALI) to Present New Clinical Data of LB1148 for Preventing Adhesions in Conjunction with Next Big Thing Session at Society of American Gastrointestinal and Endoscopic Surgeons 2022 Annual Meeting
Company to Present Adhesions Prevention Data on Wednesday, March 16, 2022, at 8:30 a.m. ETCARLSBAD, Calif., March 09, 2022 (GLOBE...
Assertio Reports Fourth Quarter and Full Year 2021 Financial Results
$32.2 Million Fourth Quarter Net Product Sales, a 7% Increase from Fourth Quarter 2020 and $109.4 Million Full Year Net Product...